Home Cart Sign in  
Chemical Structure| 2254805-62-2 Chemical Structure| 2254805-62-2

Structure of ZX-29
CAS No.: 2254805-62-2

Chemical Structure| 2254805-62-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ZX-29 is an ALK inhibitor with strong inhibitory effects on ALK and its variants. It shows significant efficacy in treating ALK mutation-positive cancers, such as non-small cell lung cancer.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ZX-29

CAS No. :2254805-62-2
Formula : C23H28ClN7O3S
M.W : 518.03
SMILES Code : O=S(=O)(NC=1C=CC=CC1NC2=NC(=NC=C2Cl)NC3=CC=C(C=C3OC)N4CCN(C)CC4)C
MDL No. :MFCD34470006

Safety of ZX-29

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of ZX-29

RTK

Isoform Comparison

Biological Activity

Description
ZX-29 is a highly potent and selective ALK inhibitor, demonstrating IC50 values of 2.1 nM, 1.3 nM, and 3.9 nM for ALK, ALK L1196M, and ALK G1202R mutations, respectively. It shows no activity against EGFR. ZX-29 promotes apoptosis by triggering endoplasmic reticulum (ER) stress and overcomes cellular resistance due to ALK mutations. Additionally, ZX-29 induces protective autophagy and exhibits antitumor effects[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.65mL

1.93mL

0.97mL

19.30mL

3.86mL

1.93mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories